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Danielle C. Jordan6, Xiaomin Chen3, Shawn M. Lyons7,8, John Crutchley2, Paul Anderson7,8, Marko E. Horb6, Amy S. Gladfelter2,6,9***, and
Jimena Giudice3,4,10***
Fragile-X mental retardation autosomal homologue-1 (FXR1) is a muscle-enriched RNA-binding protein. FXR1 depletion is
perinatally lethal in mice, Xenopus, and zebrafish; however, the mechanisms driving these phenotypes remain unclear. The FXR1
gene undergoes alternative splicing, producing multiple protein isoforms and mis-splicing has been implicated in disease.
Furthermore, mutations that cause frameshifts in muscle-specific isoforms result in congenital multi-minicore myopathy. We
observed that FXR1 alternative splicing is pronounced in the serine- and arginine-rich intrinsically disordered domain; these
domains are known to promote biomolecular condensation. Here, we show that tissue-specific splicing of fxr1 is required for
Xenopus development and alters the disordered domain of FXR1. FXR1 isoforms vary in the formation of RNA-dependent
biomolecular condensates in cells and in vitro. This work shows that regulation of tissue-specific splicing can influence FXR1
condensates in muscle development and how mis-splicing promotes disease.
Introduction
Fragile-X mental retardation autosomal homologue-1 (FXR1) and
FXR2 are vertebrate homologues of the Fragile-X mental
retardation-1 (FMR1) gene. These genes encode three RNA-
binding proteins (RBPs) that comprise the Fragile-X (FraX)
protein family (Zarnescu and Gregorio, 2013). FraX proteins
regulate mRNA transport, stability, and translation (Darnell
et al., 2009). While FMR1 is associated with neuronal func-
tions, FXR1 is highly enriched in striated muscles where it lo-
calizes to the Z-discs and costameres and is associated with
muscle function in multiple organisms (Mientjes et al., 2004;
Huot et al., 2005; Van’t Padje et al., 2009; Whitman et al., 2011;
Zarnescu and Gregorio, 2013).
Alternative splicing results in several FXR1 isoforms with
varying abundances in different cell types (Khandjian et al.,
1998; Kirkpatrick et al., 1999). Isoform balance is altered in
myotonic dystrophy (Orengo et al., 2008), facioscapulohumeral
muscular dystrophy (Davidovic et al., 2008), and diabetes
(Nutter et al., 2016), suggesting that FXR1 precursor mRNA
(pre-mRNA) splicing is central to function. Supporting this,
mutations causing frameshifts in muscle-specific isoforms are
associated with congenital multi-minicore myopathy in humans
(Estañ et al., 2019). However, it is unclear whether phenotypes
arise from neomorphic frameshifts or loss of muscle-specific
protein sequences (Estañ et al., 2019). So far, the phenotypes
of FXR1 manipulation have been observed using methods that
affect all splice isoforms. Thus, the mechanism relating FXR1
pre-mRNA splicing to its function in muscle development is not
understood. Therefore, we examined the importance of muscle-
specific FXR1 splicing in development.
Muscle-specific FXR1 isoforms contain a longer primary se-
quence than in other tissues, with a predicted 300-aa-long
intrinsically disordered domain (IDD) at the C terminus. Nu-
merous RBPs contain disordered or low-complexity sequences
that are associated with biomolecular condensation or liquid–
liquid phase separation (LLPS; Banani et al., 2017). Biomolecular
condensation is now appreciated as a common mechanism for
compartment formation in the nucleus and the cytoplasm. These
assemblies are not delineated by membranes but nevertheless
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are discrete bodies from the surrounding cytosol or nucleoplasm
(Banani et al., 2017). Depending on the composition, condensates
vary in their material properties from highly dynamic liquids to
more solid- or gel-like states (Berry et al., 2018). The possible
functions of condensates include colocalization, regulation of
biochemical reaction rates, and stress sensing (Alberti et al.,
2019). Many condensates contain RNA, and in some cases,
RNA is essential for the demixing process (Elbaum-Garfinkle
et al., 2015; Zhang et al., 2015). We postulated that alternative
splicingmay regulate the IDD and thus FXR1 condensation. RNA-
rich granules are prominent in large cells such as neurons where
transport granules package mRNAs for local translation (Kiebler
and Bassell, 2006) and in multinucleated fungi where they
promote local control of the cell cycle and cell polarity (Lee et al.,
2013, 2015). We hypothesized that alternative splicing events
within the IDD of FXR1 regulate biomolecular condensates for
patterning developing muscle.
In this study, we examined the splicing patterns of Fxr1 pre-
mRNA and observed that blocking the expression of muscle-
specific isoforms leads to alterations in Xenopus development
in vivo and in cultured muscle cell differentiation. We further
found that FXR1 forms spherical, liquid-like assemblies in both
developing myotubes and cultured U2OS cells and more gel-like
assemblies in vitro. Additionally, both disordered sequences and
RNA binding contributed to condensate assembly and different
isoforms vary in the properties of the condensates they form. In
summary, this study links alternative splicing of FXR1 to LLPS in
muscle development and disease.
Results
Splicing of fxr1 exon 15 impacts the development of Xenopus
Recessive mutations in muscle-specific isoforms of FXR1 are
associated with congenital multi-minicore myopathy in humans
(Estañ et al., 2019). These mutations result in a frameshift in
FXR1 transcripts containing exon 15. It is unclear whether multi-
minicore myopathy is the result of exon 15 loss, a neomorphic
function conferred by the frameshift, or both. To investigate
FXR1 exon 15 function in development, we removed or mutated
this exon in Xenopus laevis and Xenopus tropicalis. We chose
Xenopus because there are only two characterized Fxr1 splice
isoforms, which differ solely by the inclusion of exon 15 (Huot
et al., 2005). Furthermore, protein sequences of exon 15 from X.
tropicalis and the two alloalleles of X. laevis, 5S and 5L, differ
from mouse and human by only one aa (Fig. 1 A).
To identify the role of fxr1 exon 15 inclusion in Xenopus de-
velopment, delivery of a morpholino antisense oligonucleotide
(MO) was chosen to block the splicing recognition of exon 15 in
X. tropicalis (Fig. 1 B) as this species is diploid with a single fxr1
gene. We injected transgenic X. tropicalis embryos where the
cardiac actin promoter drives RFP expression to label the de-
veloping somites (Hartley et al., 2001) at the one- or two-cell
stage with aMO that binds the junction between fxr1 exon 15 and
intron 15 (mo-e15i15) or control MO (mo-control). Blockage of
exon 15 was confirmed by RT-PCR (Fig. 1 B). The mo-
e15i15–treated embryos showed a loss of the longer exon 15–
containing transcripts compared with embryos injected with
the mo-control (Fig. 1 B). Compared with uninjected or mo-
control–treated embryos, the mo-e15i15–injected embryos ex-
hibited severe morphological defects including curved tails and
defects in somite formation (Fig. 1, C and D), consistent with Fxr1
role in somite andmuscle development inX. laevis (Huot et al., 2005).
We next sought to compare the effect of exon 15 loss to
mutations that create frameshifts, which would mimic patient
mutations. For this, we used two approaches: CRISPR/Cas9 ed-
iting of exon 15 and blocking the exon 15 splice site using MOs
(Fig. 1 E). For these experiments, we chose X. laevis and used a
second MO that targets the intron 14 and exon 15 junction (mo-
i14e15) to complement the X. tropicalis results. Two single guide
RNAs (sgRNAs) were designed to target the 39 end of exon 15 for
both fxr1.L and fxr1.S genes, denoted T1 and T3 (Fig. 1 E), creating
a frameshift in exon 15–containing transcripts (Fig. S1). Compared
with uninjected or mo-control–treated embryos, mo-i14e15– or
sgRNA (T1/T3)–injected embryos differed significantly at stage 35-
36 of development, displaying similar gross morphological defects
(Fig. 1 E). These alterations included tail curving to varying de-
grees of severity, closely mimicking those observed in X. tropicalis
(Fig. 1, B–D). Remarkably, the observed phenotypes are also sim-
ilar to the pan-isoform knockdown of fxr1 in X. laevis (Huot et al.,
2005; Gessert et al., 2010), suggesting that the majority of Fxr1
function is derived from the isoform containing exon 15.
We next assessed the impact of loss or frameshift of fxr1 exon
15 on somites using a transgenic line with GFP-labeled somites
(Latinkić et al., 2002). We imaged GFP signal in embryos at
stages 35–38 injectedwith sgRNAs (T1/T3) ormo-i14e15. Compared
with control tadpoles, the sgRNA (T1/T3)– or mo-i14e15–injected
tadpoles exhibited gross abnormalities in somite formation, in-
cluding failure to segment (Fig. 1 F), similar to those observed to
fxr1 pan-isoform knockdown (Huot et al., 2005) and our experi-
ments in X. tropicalis (Fig. 1 D). We finally confirmed that deletion
of exon 15 using CRISPR/Cas9 editing with four sgRNAs targeting
introns 14 (T7L, T7S) and 15 (T8L, T8S) resulted in a similar phe-
notype (Fig. 1 G) to that obtained using mo-i14e15 (Fig. 1 F).
Together, our data show that mis-splicing of fxr1 exon 15 in
Xenopus development results in somite formation defects similar
to those observed when all Fxr1 isoforms were depleted in X.
laevis (Huot et al., 2005). This suggests that the highly conserved
protein sequence of exon 15 is essential for Xenopus development
and that most of the function of Fxr1 is derived from exon 15–
containing proteins.
Alternative splicing of Fxr1 pre-mRNA is tissue and
developmental stage specific
We next confirmed the splicing patterns observed in Xenopus
development are conserved in mammals. In mice and humans,
the FXR1 gene contains 17 exons (Fig. 2 A) and gives rise to
multiple protein isoforms (Fig. 2 B) via alternative splicing
(Kirkpatrick et al., 1999). Notably, exon 16 inclusion induces a
frameshift that increases protein length and alters aa composi-
tion (Fig. 2 B). Inspection of deep RNA-sequencing data from
C2C12 cell differentiation (Singh et al., 2014) and mouse heart
and skeletal muscle development (Giudice et al., 2014; Brinegar
et al., 2017) revealed that exons 15 and 16 are regulated by al-
ternative splicing during myogenesis and between birth and
Smith et al. Journal of Cell Biology 2 of 19
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adulthood in striated muscles. Previously, alternative splicing
of Fxr1 pre-mRNA in adult mouse tissues was noted, but not
quantitatively analyzed (Kirkpatrick et al., 1999; Huot et al.,
2005; Davidovic et al., 2008).
Here, we characterized the splicing patterns of exons 12, 13,
15, and 16 and quantitatively measured the percent spliced in
(PSI) (Wang et al., 2008) of each exon at different stages of
mouse development by RT-PCR. We observed that exon 15 was
Figure 1. Splicing of fxr1 exon 15 regulates Xenopus development. (A) Conservation of FXR1 exon 15-aa sequences in human (Homo sapiens), mouse (Mus
musculus), X. laevis, X. tropicalis, and zebrafish (Danio rerio). Red indicates deviation relative to mouse/human sequence. Mouse exon 15 is underlined. (B) A MO
targeting exon 15 (mo-e15i15) was used in X. tropicalis. Successful blocking of exon 15 inclusion was confirmed by RT-PCR. (C) Representative images of
uninjected embryos or those injected with a mo-control or the mo-e15i15 (X. tropicalis) at stage 45. (D) X. tropicalis embryos at stage 45. RFP signal marks the
somites of uninjected, mo-control, or mo-e15i15–treated embryos. (E) Position of mo-i14e15 and sgRNAs within the X. laevis genome. Representative images
and quantification of normal or two abnormal phenotypes (1 and 2) for uninjected, mo-control, mo-i14e15, or sgRNA-treated embryos. (F and G) X. laevis
embryos at stages 35–38. GFP signal marks the somites of uninjected, injected (mo-control or mo-i14e15), and Cas9 protein injected with sgRNAs targeting
exon 15 or introns 14 and 15 for both 5S and 5L. White rectangles indicate the region of the somites magnified in the insets in (F). All scale bars, 1 mm. Fig. 1, E
and F, is linked to Fig. S1.
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Figure 2. Alternative splicing regulates FXR1 in a tissue- and developmental stage–specific manner. (A)Mouse Fxr1 gene structure. The arrow indicates
transcription initiation site. Numbers indicate the exons. Alternatively spliced exons are indicated in colors. (B) Location of the alternatively spliced region
within FXR1. Darker purple in isoforms A and B denotes different amino acids (AA). C, C-terminus; N, N-terminus; NES, nuclear export signal; NLS, nuclear
localization signal. Blue, yellow, red, and pink colors correspond to the alternatively spliced exons shown in A. IDD is colored in purple, the RGG in green, and
the KH domains in orange. (C and D) Splicing of exons 15 and 16 of Fxr1 pre-mRNA was evaluated by RT-PCR in nonstriated muscles of neonatal (P4.5) and
adult (4-mo-old) mice (C). The PSI of exon 15 or exon 16 and the abundance of transcripts evaluated by densitometry (D). (E) Fxr1 pre-mRNA splicing was
similarly evaluated in mouse skeletal muscles (sk muscle) and hearts at embryonic day 15.5 (E15.5), P4.5, and adulthood. (F) FXR1 pre-mRNA splicing was
similarly evaluated in commercial human RNA samples. Data are means ± SEM, *P ≤ 0.05 (one-way ANOVA test with Bonferroni correction for multiple
comparisons), n = 3–4 (mouse tissues), n = 2 (fetal human tissues), n = 3 (adult human tissues). Fig. 2 is linked to Fig. S2.
Smith et al. Journal of Cell Biology 4 of 19
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rarely included in kidney, spleen, pancreas, liver, lung, intes-
tine, or brain at postnatal day 4.5 (P4.5) or adulthood (∼4mo old;
Fig. 2, C and D). By contrast, exon 15 was more included in adult
hearts and skeletal muscles than in neonates or embryos (Fig. 2,
D–E). While exon 16 was partially included in nonstriated
muscle tissues, its inclusion increased during postnatal devel-
opment only in striated muscles (Fig. 2, C–E). We further vali-
dated that splicing transitions of both exons 15 and 16 are
conserved in human heart and skeletal muscle (Fig. 2 F).
The splicing events in exons 12 and 13 displayed different
patterns than exons 15 and 16. All the examined tissues included
the entire exon 13, while the insert in exon 12 was mostly
skipped in nonmuscle tissues (Fig. S2, A and B). By contrast, in
striated muscles, almost half the transcripts included the insert
(Fig. S2 B). Unlike exons 15 and 16, the 87-nt insert in exon 12
was not regulated during development in striated muscles.
We then confirmed that the detected splice variants were
translated using an antibody against the N terminus of FXR1 that
recognizes all isoforms in Western blots on adult mouse tissue
(Fig. S2 C). Brain and liver expressed a small protein band
(∼60–65 kD) corresponding to isoforms A and B. Kidney ex-
hibited the same band as well as an additional low molecular
weight band (∼45 kD; Fig. S2 C), not corresponding to any
known FXR1 isoform (Fig. 2 B). Heart and skeletal muscle ex-
pressed mostly the long FXR1 isoform of ∼80 kD (Fig. S2 C),
corresponding to a combination of isoforms E and F. Overall,
these data indicate that Fxr1 splicing is conserved and leads to
the expression of different protein variants in specific tissues
and developmental stages.
C2C12 cell differentiation recapitulates Fxr1 splicing
transitions of muscle development in vivo
Given the conserved regulation of Fxr1 transcripts by splicing,
we next identified a mammalian cell system, C2C12 cells, where
we could examine the functional consequences of splicing. Dif-
ferentiation of C2C12 myoblasts into myotubes (myogenesis) is a
well-established model to study molecular aspects of skeletal
muscle biology in culture (Burattini et al., 2004). A previous
study implicated FXR1 in muscle cell proliferation (Davidovic
et al., 2013), but its role in differentiation was not investi-
gated. By using siRNAs, we found that FXR1-depleted cells (Fig.
S3, A and B) formed fewer myotube-like cells than controls (Fig.
S3 C). We further identified that this phenotype was due to an
∼50–80% decrease in cell–cell fusion (Fig. S3 D). Both siRNAs
used showed this decrease, with si-Fxr1-#2 giving the strongest
fusion phenotype and a reduction in the number of nuclei per
field of view (Fig. S3 E). Collectively, these results demonstrate
that FXR1 is required for myoblast fusion.
We then systematically quantified the splicing of exons 12, 13,
15, and 16 during myogenesis. Two days after differentiation
induction, exons 15 and 16 were highly included (Fig. 3 A), re-
capitulating the findings observed in muscle development. Un-
like exons 15 and 16, C2C12 cells always include exon 13 (Fig. 3 B).
This is consistent with the above-mentioned RNA-sequencing
dataset (Singh et al., 2014) and previous reports indicating the
alternative 39 splice site in exon 13 usage is rare (Kirkpatrick
et al., 1999). The insert in exon 12 was mostly skipped in
myoblasts, while it was included in ∼50% of myotube tran-
scripts (Fig. 3 B). These findings suggest that myotubes express
isoforms E and F at a 1:1 ratio. Finally, we confirmed that during
cell differentiation smaller protein isoforms A (539 aa) and B
(568 aa) are replaced by the largest protein isoforms E (677 aa)
and F (648 aa; Fig. 3 C). Collectively, these data suggest that
C2C12 cell differentiation reproduces Fxr1 splicing transitions
that take place during striated muscle development in vivo,
leading us to use this culture model for our molecular studies.
Fxr1 splicing produces distinct intrinsically disordered proteins
that form condensates
What is the functional consequence of producing splice isoforms
of FXR1 with C-terminal extensions in myotubes? To answer
this question, we examined the disorder tendency of the C ter-
mini of isoforms A versus E via the intrinsically unstructured
proteins predicted disorder (IUPRED) algorithm (Dosztányi
et al., 2005a,b). We found that while the C termini of both iso-
forms have IDDs, isoform E has a predicted IDD of ∼300 aa,
roughly twice as long as isoform A (∼160 aa; Fig. 4 A). Because a
frameshift occurs when exon 16 is included, the different iso-
form IDDs also vary by aa composition; however, both are rich in
serine and arginine residues. In serine/arginine-rich splicing
factors, these regions are subject to posttranslational mod-
ifications (PTMs), modulating their propensity for disorder
(Haynes and Iakoucheva, 2006; Xiang et al., 2013; Wang et al.,
2014). Thus, both the IDD length and the potential for PTMsmay
regulate FXR1 activity during development.
FXR1 is an RBP (Siomi et al., 1995; Zhang et al., 1995), and
numerous RBPs contain IDDs that aid in LLPS (Wang et al., 2014;
Uversky et al., 2015; Pak et al., 2016; Banani et al., 2017). We
therefore hypothesized that FXR1 may form condensates in the
myotube cytosol, with isoform E having a highest propensity due
to its extended IDD. To determine whether FXR1 undergoes LLPS,
we visualized FXR1 in C2C12 cells. Immunolabeling of endogenous
FXR1 revealed punctate structures throughout the myotube cyto-
sol (Fig. 4 B). To examine the properties of these structures, Fxr1
tagged with GFP (Fxr1-GFP) was transiently transfected into C2C12
myoblasts that were then differentiated for 2 d. We observed
FXR1-GFP spherical structures in cells that readily fused, sug-
gesting that FXR1 forms liquid-like assemblies (Fig. 4 C). These
droplets were too small and dynamic for partial FRAP studies to
accurately assess exchange and rearrangement dynamics. Using
an FXR1 antibody against the C terminus that does not detect
isoform A or B, Western blots were performed on differentiating
C2C12 cells (Fig. 4 D). We found that after 2 d of differentiation, a
portion of FXR1 is visible in the pellet, which may correspond to
assembly into insoluble higher order structures. These data indi-
cate that, like other intrinsically disordered RBPs, FXR1 forms
higher order assemblies and liquid-like droplets in cells.
We next asked whether FXR1 condensates are dependent
upon alternative splicing. We used MOs to redirect endogenous
splicing of exon 15 (mo-1) and/or exon 16 (mo-2) in C2C12 cells.
MOs were designed to target the splice sites and block exon
recognition, thus promoting exon skipping (Fig. S3 F).MOswere
delivered to naive C2C12 cells that were then differentiated
for 4 d. Both mo-1 and mo-2 blocked exon 15 or 16 inclusion,
Smith et al. Journal of Cell Biology 5 of 19
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respectively (Fig. S3, G and H), without altering total mRNA
levels (Fig. S3 I). These MOs also produced smaller protein iso-
forms excluding these exons (Fig. 4 E). To determine whether
altering endogenous Fxr1 splicing in myotubes caused morpho-
logical differences in condensation, we analyzed cells treated
with the MOs by immunofluorescence with antibodies against
endogenous FXR1. We found that cells lacking exons 15 and 16
formed smaller and fewer FXR1 puncta than control cells ex-
pressing the long isoforms. We quantified this effect by mea-
suring the variability in fluorescence intensity of endogenous
FXR1 within individual cells and determining the coefficient of
variation (CV) of the fluorescent signal (Fig. 4, F and G). Con-
sistent with having fewer, smaller FXR1 structures, cells with
both exons 15 and 16 targeted have the smallest CV, indicative of
less heterogeneity in the localization due to more soluble, ho-
mogeneously distributed protein (Fig. 4, F and G). We conclude
that alternative splicing of Fxr1 during myogenesis functions in
part to produce isoforms more capable of condensation.
FXR1 assemblies are protein concentration dependent
If FXR1 is undergoing phase separation to form puncta in muscle
cells, assembly should be protein concentration dependent. To
titrate FXR1 expression, isoform E was placed under the control
of a tetracycline (Tet)-inducible promoter in U2OS human os-
teosarcoma fibroblast cells that had FXR1, FXR2, and FMRP genes
knocked out by CRISPR/Cas9 editing (U2OSΔFFF). It was im-
portant to use the triple knockout to ensure that endogenous
FraX proteins were not acting as seeds for droplets formed with
exogenous FXR1. We found that 25 ng/ml Tet-induced expres-
sion of mNeonGreen (mNG)-tagged FXR1 isoform E produces
approximately endogenous levels (Fig. 5 A). We hypothesized
that isoform E should exhibit increased condensation capacity
compared with isoform A because of the data presented in Fig. 4.
We therefore imaged live U2OSΔFFF cells expressing either
mNG-tagged FXR1 isoform A or E at increasing levels of Tet
induction (Fig. 5 B). Cellular condensates were observed at levels
below the endogenous protein concentration for both isoforms
(Fig. 5 B). In support of concentration-dependent condensation,
the number of cells with droplets increased with Tet concen-
tration (Fig. 5 C). The proportion of cells with condensates was
not statistically different between isoforms A and E. However,
we noticed that the condensate morphology differed between
the two isoforms (Fig. 5 B). Isoform A formed large spherical
droplets, while isoform E formed more irregular-shaped bodies.
Figure 3. C2C12 cell differentiation reproduces Fxr1 splicing transitions. RNA or protein was extracted at undifferentiated stage (undiff) and differen-
tiating (D0 to D8) C2C12 cells. (A) Splicing of exons 15 and 16 was evaluated by RT-PCRs. The PSI was determined by densitometry. (B) Inclusion or skipping of
the 87-nt insert in exon 12 of Fxr1 pre-mRNA. (C) Protein lysates were analyzed by Western blotting. Data are means ± SEM, *P ≤ 0.05 versus undifferentiated
stage (one-way ANOVA test with Bonferroni correction), n = 3–5 experiments. Fig. 3 is linked to Fig. S3, A–E.
Smith et al. Journal of Cell Biology 6 of 19
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Figure 4. Alternative splicing results in disordered protein isoforms that are capable of phase separation. (A) Disorder predictions based on the
primary aa sequence of FXR1 isoforms A and E using the IUPRED algorithm. (B) Endogenous FXR1 protein was visualized by immunofluorescence in myotubes
using an antibody against the N terminus of FXR1 (recognizes all splice variants). Representative images depicting FXR1 puncta. Scale bar, 5 µm. Inset shows
droplets magnified fourfold. Dapi, 69-diamidino-2-phenylindole. (C) Time-lapse acquisition of human isoform 2 FXR1-EGFP (pAGB828). Two condensates (red
and blue arrows) fuse together to form one (purple arrow). Scale bar, 1 µm. (D) C2C12 myoblasts were differentiated for 1, 2, or 3 d (D1, D2, D3). Cell lysates and
pellets were analyzed by Western blot using an FXR1 antibody specific to the C terminus of isoform E. (E–G)MOs targeting exons 15 (mo-1) and/or 16 (mo-2)
were delivered in myoblasts, and the next day cells were differentiated for 4 d. Cells were analyzed by Western blotting and immunofluorescence using an
antibody against FXR1 N terminus (E). The CV was calculated as a measurement of FXR1 condensation. P > 0.5 mo-1 versus mo-control, P < 0.001 mo-2 and
mo-1 & 2 versus mo-control (F). Representative images of MO-treated cells showing FXR1 puncta. Scale bar, 5 µm. Bottom row shows droplets magnified
fivefold (G). Data are standard box and whisker plot. Fig. 4 is linked to Fig. S3, F–I.
Smith et al. Journal of Cell Biology 7 of 19
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Figure 5. FXR1 phase separation is concentration dependent. (A)Whole-cell extracts fromWT U2OS cells or U2OSΔFFF cells transiently transfected with
either an empty vector (pAGB1139) or PCMV2xTetO2-mNeonGreen-FXR1 isoform E (pAGB1162) were prepared. Extracts were analyzed by Western blot. Right:
Quantification of protein levels normalized to a loading control. (B–G) U2OΔFFF cells were transiently transfected with an empty vector (pAGB1139),
PCMV2xTetO2-mNeonGreen-FXR1 isoform A (pAGB1189) or isoform E (pAGB1162). (B) Representative images of cells at increasing Tet concentrations. Scale bar,
5 µm. (C) Quantification of droplet formation for individual cells. n > 720 cells from three independent experiments. (D) Zoomed-in images showing examples
of irregular droplets, small spheres, and large spheres. Scale bar, 5 µm. (E) Quantification of droplet morphology. n > 185 cells from three experiments. (F–G)
The cell lysate and pellet were analyzed byWestern blot as described in A. The percentage of protein in the pellet was quantified as the amount in the pellet out
of the amount in the whole-cell extract. Data are means ± SEM. Supe, supernatant; WCE, whole-cell extract.
Smith et al. Journal of Cell Biology 8 of 19
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To evaluate droplet morphology, we assigned all the visualized
cells to one of the following categories: (1) irregular or nonspherical-
shaped bodies, (2) small spherical droplets, or (3) large spherical
droplets (Fig. 5 D). Irregular condensates increased in both iso-
formswith protein concentration, with amore pronounced trend
for isoform E (Fig. 5 E) than for isoform A. Unexpectedly, isoform
A produced more large, spherical droplets. Consistently, both
isoforms were enriched in the pellet with increasing Tet con-
centrations (Fig. 5, F and G). Despite having a shorter IDD, a
higher proportion of isoform A was detected in the pellet at all
Tet concentrations (Fig. 5, F and G), suggesting the composition
rather than length of the IDD is important for the traits of the
condensates. We suspect that there may be specific PTM differ-
ences between myotubes and U2OS cells that could explain the
differences between isoforms A and E in these two contexts.
Nevertheless, droplet formation is concentration dependent,
consistent with phase-separated assembly, morphology, and
droplet properties.
We next examined the propensity of FXR1 to phase separate
in vitro. To confirm RNA dependence and isoform-specific dif-
ferences of FXR1 for droplet formation in vitro, we purified
mouse FXR1 isoforms E and A recombinantly from BL21 cells
using a 6xHis-GB1 tag (where GB1 is the B1 domain of protein G;
Zhang et al., 2015). GB1 was essential to keep both isoforms A
and E soluble during the purification. We observed that in the
presence of luciferase RNA, both isoforms E and A had the
tendency to slowly aggregate (Fig. 6 A; and Fig. S4 A) rather than
form the droplets as observed in vivo (Figs. 4 and 5). Luciferase
RNA was chosen as it has previously been shown to induce
phase separation of FMR1, which has a similar RNA-binding
domain as FXR1 (Tsang et al., 2019). There were subtle differ-
ences in the morphology of the aggregates between isoforms E
and A. Isoform E formed larger aggregates at lower concentra-
tion (2 µM) than isoform A, which is consistent with isoform E
containing a longer disordered sequence. Thus, RNA promotes
higher order assemblies of FXR1 in vitro.
We postulated that a PTM not present in the bacteria was
responsible for inducing the droplet (rather than aggregate)
behavior in mammalian cells. To this end, we characterized
potential phosphorylation sites in FXR1 sequences. Strikingly, a
number of serine phosphorylation sites were predicted in the
IDD of isoforms A and E, with more sites in the longer IDD of
isoform E (Fig. 6, B and C). Interestingly, a similar concentration
of phosphorylation sites in the IDD was not observed in the
FMR1 sequence (Fig. S4 B). To test the importance of FXR1
phosphorylation in vitro, we treated isoforms A and E with ca-
sein kinase 2 (CK2) either in the presence or absence of ATP and
then incubated the resulting protein either in the presence or
absence of luciferase RNA. We confirmed that phosphorylation
induced a gel shift in FXR1 protein bands (Fig. S4 C), with a more
significant shift in size for isoform E, which had more predicted
sites for CK2 phosphorylation (Fig. 6 B).
Consistent with our previous results, RNA promoted aggre-
gation in both control samples of isoform A and E (Fig. S4 D).
However, phosphorylation tended to reduce (isoform E) or block
entirely (isoform A) the aggregation of FXR1 (Fig. 6 D; and Fig.
S4 D). Following 24 h of incubation with RNA, control-treated
isoform E formed larger aggregates than isoform A (Fig. 6 E),
whereas phosphorylation blocked aggregate formation for isoform
A or substantially reduced aggregation for isoform E (Fig. 6 D).
Phosphorylation had a minimal but significant effect in the ob-
served RNA signal within the particles at 24 h, likely due to the
reduced large particle formation (Fig. 6 G). This observation is
consistent with few predicted phosphorylation sites within the
RNA-binding domains of FXR1 (N terminus) shared between
isoforms E and A (Fig. 6 F). Taken together, our studies revealed
that at the same protein concentration in vitro, isoform E is more
prone to form aggregates than isoformA, that RNA accelerates and
increases the size of aggregates formed by both isoforms, and that
phosphorylation reduces aggregation of both isoforms A and E.
This evidence suggests that PTMs such as phosphorylation are
critical to the regulation of FXR1 functions in vivo.
FXR1 assemblies are RNA-binding domain dependent
The in vitro data suggest RNA is critical for the formation of
FXR1 assemblies. To determine which FXR1 domains are
required for condensation, we created mutations in the K Ho-
mology (KH) domains (Fxr1KH1, Fxr1KH2, Fxr1KH1/2), the arginine-
glycine-glycine containingmotif (RGG) box (Fxr1ΔRGG), and both a
partial truncation (Fxr11-490) and complete truncation of the IDD
(Fxr11-374) of the Fxr1 coding sequence in the Tet-inducible mNG-
tagged isoform E construct (Fig. 7 A). We then imaged live
U2OSΔFFF cells transiently transfected with each mutant in-
duced to endogenous levels and quantified the proportion of cells
with droplets (Fig. 7, B and C). When the three RNA-binding
domains were mutated (Fxr1ΔRGG KH1/2), no condensates were
detected. Intermediate phenotypes were observed for the single
RNA-binding mutations, implying that the RNA-binding
domains are partially redundant for LLPS. All of the five RNA-
binding–deficient constructs had droplet formation significantly
different from WT.
We next investigated the role of the IDD in droplet formation.
When the IDD was truncated to the RGG (Fxr11-490), we observed
significantlymore cells with droplets thanWT, implying that the
longer IDD may limit LLPS nucleation. Truncation of the entire
IDD (Fxr11-374) did not abolish droplet formation, suggesting that
the disordered sequence is not essential for phase separation
even in cells with no WT FraX proteins (Fig. 7, B and C). These
data show that the relationship between IDD length and FXR1
droplet formation is nonlinear. The whole-cell extract from
transfected cells showed that none of the mutant proteins have
reduced expression (Fig. 7 D). Western blots comparing the ly-
sate to the pellet confirmed our observations of condensation
from microscopy, with FXR1ΔRGG and FXR11-490 showing the
most protein in the pellet and FXR1KH1/2 and FXR1ΔRGG KH1/2
showing the least. While the morphologies of FXR1KH1/2 and
FXR1ΔRGG KH1/2 are different (Fig. 7 C), they show similar results
in the Western blot assay (Fig. 7 D).
Droplet morphologies were also affected by some of these
mutations. Because the Fxr1ΔRGG KH1/2mutation abolished droplet
formation, we did not include this mutant in these analyses.
Isoform E showed mostly irregular droplets with some small
spherical droplets (Fig. 7 E), suggesting that small droplets are
coalescing incompletely into irregularly shaped assemblies.
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Mutation of the KH domains individually or together increased
the percentage of cells with small spherical droplets. Without
the KH domains, RNA binding is presumably mediated through
the RGG box, which may associate with a different set of RNAs.
These RGG-mediated associations still enable small droplets to
form, but they have limited or slowed fusion. Deletion of the
RGG box alone did not alter droplet formation or morphology,
implying that the KH domains are the major RNA-binding do-
mains for phase separation. Interestingly, truncation of the IDD
back to the RGG box (Fxr11-490) did not significantly alter droplet
morphology, while deletion of the entire IDD (Fxr11-374) caused
most cells to have large spherical droplets. This is surprising
given that IDDs in other proteins are crucial for this phenotype.
These results raise the possibility that RNA interactions are
more critical in driving the phase separation of FXR1 than the
IDD and that the IDD primarily impacts the material properties
of the condensates.
Discussion
FXR1 is hypothesized to regulate mRNA translation, localization,
and stability (Mientjes et al., 2004; Vasudevan and Steitz, 2007;
Figure 6. RNA promotes and phosphorylation inhibits FXR1 association in vitro. (A) Representative images of FXR1 isoforms A and E aggregates (2 or
4 µM) in the presence or absence of luciferase RNA (magenta). Scale bars, 10 µm. (B) Predicted disorder (IUPRED), unspecified kinase score and CK2 kinase
scores for serine are marked for each aa. (C) Representative images of isoform A and E aggregates with or without RNA and with or without phosphorylation
(Phos). Scale bars, 10 µm. (D–G)Quantification of particle area (D), RNA fluorescence within particles (E), number of particles (F), and number of particles >0.3
µm2 using the images represented in C. ***P < 0.001, **P < 0.01, *P < 0.05 (Student’s t test, two sided). ns, not significant.
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Davidovic et al., 2013; Zarnescu and Gregorio, 2013; Cook et al.,
2014; Majumder et al., 2016; Patzlaff et al., 2017); however, there
is little known about the mechanisms of function of FXR1 in
physiological or pathological contexts. Here, we show quanti-
tative differences in FXR1 isoforms arising from tissue-specific
and developmentally regulated alternative splicing and a func-
tional role for fxr1 splicing in myotube formation and Xenopus
development. Alternative splicing of FXR1 pre-mRNA leads to
the expression of distinct protein isoforms that vary substan-
tially in the length of the C-terminal IDD. FXR1 can condense
into liquid-like droplets in an RNA-dependent manner. We
observed that the different splice isoforms vary in droplet
morphology. These data provide a role for developmentally
controlled splicing in regulating the formation of biomolecular
condensates.
We hypothesized that FXR1 isoforms specifically expressed in
myotubes might be important for proper function of muscle
cells. Our in vivo studies in Xenopus revealed that fxr1 exon
15 mis-splicing resulted in somite formation defects, while
blocking exon 15 inclusion in vitro does not seem to impact
myotube formation. One possible explanation of this discrep-
ancy is that MOs are delivered using a liposomal reagent (en-
doporter) in the cells that we know helps cell fusion. However,
we did observe FXR1 condensation in myotubes, and this con-
densation was reduced when we blocked the alternative splicing
required to form the extended IDD (Fig. 4). However, con-
densates were still observed for the shorter isoform A and for
morpholino-treated cells, which shortens IDDs. This suggests
that the change in protein sequence via splicing is important for
regulation of condensation with RNA, not for conferring the
Figure 7. Phase separation is RNA binding dependent. (A) Location of mutations in the domains of isoform E. (B and C) U2OSΔFFF cells were transfected
with WT PCMV2xTetO2-mNeonGreen-FXR1 isoform E (pAGB1162), plasmids with mutated KH1 (pAGB1171), KH2 (pAGB1172), KH1/2 (pAGB1173), RGG (pAGB1174),
RGG and KH1/2 (pAGB1175), complete IDD (pAGB1176), or partial IDD (pAGB1177). All constructs were induced with 25 ng/ml Tet to endogenous levels. Black Xs
indicate mutated regions. (B) Quantification of droplet formation. n > 350 cells from three experiments. (C) Representative images of cells expressing the
different mutants. Scale bar, 5 µm. (D)Whole-cell extracts (WCE), lysate, and pellets were analyzed byWestern blotting using an antibody against FXR1. Right:
percent protein in the pellet quantified as in Fig. 5. (E) Quantification of droplet morphology using the same three categories that were used in Fig. 5. Data are
means ± SEM.
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ability to condense. We postulate that differential IDD sequences
can regulate condensation through PTMs, altered RNA targets,
and/or protein–protein interactions.
FXR1 requires RNA to form droplets, such that elimination of
all RNA-binding domains blocks LLPS (Fig. 6). The RNA-binding
sites are partially redundant. RNA drives the phase separation of
other RBPs that undergo LLPS, including WHI3, LAF-1, and
multiple P-granule proteins (Elbaum-Garfinkle et al., 2015;
Zhang et al., 2015; Smith et al., 2016; Langdon et al., 2018). Our
in vitro experiments confirm that luciferase RNApromotes FXR1
aggregation, and future experimentations are needed to exam-
ine the effect of native RNA targets of FXR1. One experimental
issue in this regard is that the RNA targets of FMR1 and likely
FXR1 are quite long (Greenblatt and Spradling, 2018). To our
knowledge, this fact has made them very difficult to synthesize
with current techniques. We speculate that longer RNAs may be
required to induce droplet formation in vitro. Only isoform E
binds G-quadruplex structures (Bechara et al., 2007; Lyons et al.,
2017), which promote LLPS (Fay et al., 2017). FXR1 alsomay have
nonspecific RNA interactions via the RGG domain. It will
therefore be important to understand whether specific targets of
FXR1 are primarily driving phase separation and how the dif-
ferent modes of RNA interactions (i.e., KH versus RGG) influ-
ence droplet assembly.
One of the striking findings in this study is that a longer IDD
led to more abundant and functional condensates in myotubes
but limits FXR1 LLPS when analyzed in U2OS cells. While in
myotubes, isoform E forms more, brighter puncta, in U2OS cells
we found that the short isoform A enriches in pellets at lower
protein concentrations than the long isoform E and isoform A is
more likely to be found in very large and highly spherical
droplets. By contrast, in U2OS cells isoform E tends to be in small
or irregular droplets, which we suspect are either arrested in
fusion or very slow to fuse (Fig. 5). Given that serine/arginine-
rich sequences can be heavily impacted by PTMs, we hypothe-
size that the additional sequence provides more residues to
enhance modifications that disfavor phase separation in this
context.
Interestingly, isoforms A and E aggregate rather than form
droplets in vitro, which is quite different than results obtained
for FMR1 (Tsang et al., 2019). A potential explanation for this
difference is that phosphorylation sites of FMR1 are more evenly
distributed across the protein rather than strongly concentrated
within the IDD, as we observed in FXR1. We found that phos-
phorylation strongly suppressed the FXR1 aggregation pheno-
type observed in vitro with a stronger impact on isoform E
whose IDD contains 41 serine residues, while isoform A has 26.
Phosphorylation has a well-established role in influencing bio-
molecular condensation (Aumiller and Keating, 2016; Hofweber
and Dormann, 2019; Snead and Gladfelter, 2019) and is both
rapid and reversible. Phosphorylation has previously been
shown to either promote dissolution of granules (Wippich et al.,
2013; Rai et al., 2018) or inhibit phase separation (Rai et al.,
2018), as we found for FXR1. Interestingly, phosphorylation of
the IDD of FMR1, an FXR1 homologue, is required for its inter-
action with another RNA-binding domain, Caprin, to tune in-
teractions with RNA. Phosphorylation of FMR1 did not block
phase separation, suggesting that phosphorylation-dependent
inhibition is unique to FXR1, although the authors did not test
the full-length FMR1 or native FMR1 (Kim et al., 2019). Thus,
going forward, it is important to consider how splicing may
regulate the patterns and levels of PTMs within IDD sequences,
which may change the protein’s ability to interact with other
RBPs or RNAs.
More surprising was the analysis of proteins missing the
C-terminal IDD completely (Fig. 7 E). A fragment containing only
the N terminus and lacking any predicted IDD robustly formed
large, highly spherical droplets. The N-terminal Agenet domains
may mediate interactions with other phase-separating proteins
to recruit the truncated FXR1. In this case, the Agenet domains
would provide multivalency to contribute to the normal LLPS
process. The Agenet domains of FMR family proteins bind
methylated lysine residues (Adams-Cioaba et al., 2010); there-
fore, PTMs of binding partners could modulate FXR1 interactions
throughout development. Finally, the developmental splicing
program may alter which mRNAs are available for FXR1 interac-
tion, and depending on the identity of the bound mRNAs, the IDD
role may vary from what we see in U2OS cells.
In summary, we have shown a functional role for FXR1
splicing in development, to promote extension of an IDD rele-
vant for FXR1 condensation with RNA. The unexpected negative
effect of a longer IDD on the propensity to phase separate in
U2OS cells raises important possible mechanisms for how IDDs
may contribute to biomolecular condensates in different cell
types. Future work will determine how condensates control
translation of associated mRNAs and whether FXR1 splice iso-
forms lead to different targets during tissue identity acquisition
and maintenance. In conclusion, we link a developmental
splicing program to changes in condensation in FXR1, a mech-




Chemicals and cell culture reagents were obtained from GIBCO,
Life Technologies, Thermo Fisher Scientific, and Sigma. C2C12
cells and WT U2OS cells were purchased from American Type
Culture Collection. Human RNA samples were purchased from
the following commercial sources: (1) heart (male, 21 yr old)
from Amsbio (R1234139-50, lot no. B707146), (2) heart (male, 51
yr old) from Cell Applications Inc. (1H30-50, lot no. 1639), (3)
heart (male, 30–39 yr old) from TakaRa (636532, lot no.
1610293A), (4) skeletal muscle (female, 48 yr old) from Amsbio
(R1234171-50, lot no. B207200), (5) skeletal muscle (male, 58 yr
old) from Cell Applications Inc. (1H60-50, lot no. 1376), (6)
skeletal muscle (male and female, 20–68 yr old) from TakaRa
(636534, lot no. 1609179A), (7) heart (female, 22 wk of gesta-
tion) from Cell Applications Inc. (1F30-50, lot no. 2739), (8)
heart (male, 20–21 wk of gestation) from Agilent (540165, lot
no. 0006262824), (9) skeletal muscle (female, 22 wk of gesta-
tion) from Cell Applications Inc. (1F60-50, lot no. 2739), and
(10) skeletal muscle (female, 18 wk of gestation) from Agilent
(540181, lot no. 0006260887).
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Mice
FVB/NJ mice were purchased from The Jackson Laboratory.
Colonies were derived by mating animals. Mice were handled
following the National Institutes of Health (NIH) Guidelines for
Use and Care of Laboratory Animals that were approved by the
Institutional Animal Care and Use Committee at The University
of North Carolina at Chapel Hill.
Mouse tissue isolation
Adult (4–5 mo old) and neonatal (P4.5) mice were euthanized
using isoflurane. After cervical dislocation (adult) or decapita-
tion (P4.5), tissues were removed and frozen in liquid nitrogen.
WT C57BL/6J mouse embryos at day 15.5 were donated from Dr.
Stephanie Gupton’s laboratory (University of North Carolina at
Chapel Hill, Chapel Hill, NC). Embryos were rinsed with PBS,
the thoracic cavity was opened, and the hearts were dissected.
The epidermal layer was then removed, and the fore- and hind
limbs were excised after removing the paws. Embryonic tissue
was blotted dry and snap frozen in liquid nitrogen.
Cell culture
C2C12 undifferentiated cells (myoblasts) were maintained at
37°C under 5% CO2 in DMEM supplemented with 10% FBS
(Gemini Bio-Products), 2 mM glutamine, 100 U/ml penicillin,
and 100 µg/ml streptomycin under low confluence conditions
(<40%). For differentiation of myoblasts into myotubes, cells
were washed with PBS and then cultured in DMEM supple-
mented with 2% horse serum, 2 mM glutamine, 100 U/ml pen-
icillin, and 100 µg/ml streptomycin. U2OS cells weremaintained
at 37°C under 5% CO2 in DMEM supplemented with 10% FBS,
100 U/ml penicillin, and 100 µg/ml streptomycin. For plasmid
transfection, cells were transfected at ∼60–70% confluence with
Lipofectamine 2000 reagent (Invitrogen) following the manu-
facturer’s protocols. In Tet-experiments, 24 h after transfection,
cells were induced with Tet for 16 h and subsequently used for
the assays.
Generation of U2OSΔFFF
To create the U2OSΔFFF cell line, FXR2 was first knocked out
using a guide RNA with the sequence 59-CCCCATAGGTTCGAG
TCGCA-39 in the U2OS Tet-inducible cells. Several clones were
selected, and FXR2 protein expression was evaluated by im-
munofluorescence and Western blotting. Clone 6 was selected
for subsequent experiments. This cell linewas then cotransfected
with Cas9 and guide RNAs targeting FXR1 (59-TTCCTAGGAATC
TCGTTGGT-39) and FMR1 (59-AAGAGGCGGCACATAAGGAT-39).
Clones were selected and screened in a similar manner, and fi-
nally clone 24 was selected. All loci were sequenced to confirm
deletions in the DNA.
Plasmids
Restriction enzymes and competent cells were from New Eng-
land Biolabs (NEB). Oligonucleotides used for plasmid genera-
tion were synthesized at Integrated DNA Technologies. PCRs
were performed using iProof high-fidelity polymerase (Bio-
Rad). Sequencing was performed by Genewiz. The sequences of
the primers used for cloning are detailed in Table S1.
The mNG-tagged constructs were created by first making a
pCMV-mNeonGreen plasmid (pAGB1103). The mNG ORF was
amplified from pAGB1070 (pNCS-mNeonGreen AmpR; Allele Bio-
technology) with the primers AGO2195 and AGO2196 via PCR.
The resulting product was cloned into pAGB879 (PCMV-Fxr1isoE-
tGFP AmpR; Origene) cut with BglII and SacI (to remove Fxr1-
turboGFP from the plasmid) using the NEBuilder HiFi DNA
assembly reaction (NEB). To make pAGB1111, Fxr1 isoform E
was then amplified with primers AGO2202 and AGO2203 via
PCR and cloned via NEBuilder HiFI DNA assembly reaction
into pAGB1103 previously cut with NotI and SacII to make an
N-terminally tagged construct. To create the C-terminal
truncations where the IDD was either truncated back to the
RGG (Fxr11-490) or completely truncated (Fxr11-374), the same
approach was taken using different reverse primers to only
amplify the first 1,122 bp of the ORF (pAGB1176 = Fxr11-374,
reverse primer was AGO2206) or the first 1,470 bp of the ORF
(pAGB1177 = Fxr11-490, reverse primer was AGO2207). All of the
mutations were created in the Tet-inducible mNG-tagged
isoform E construct.
To mutate the KH domains, point mutations were created in
the conserved GxxG protein loop required for nucleic acid
binding in either the first (Fxr1KH1), second (Fxr1KH2), or both
domains (FXR1KH1/2). These mutations should abrogate nucleic
acid binding to the KH domain without destabilizing protein
structure (Hollingworth et al., 2012; Wong et al., 2013; Wang
et al., 2015) These point mutations and deletions were created
via site-directed mutagenesis using the following primers for
each mutation: T236D H237D (KH1), AGO1869 and AGO1870 and
K299D N300D (KH2), AGO1871 and AGO1872. To analyze the
effect of loss of the RGG box, this region was completely re-
moved (Δ464–490) to create Fxr1ΔRGG using site-directed muta-
genesis with primers AGO1873 and AGO1874.
To move all mNG-tagged mutations and truncations into the
Tet-inducible plasmid, pAGB1139 (PCMV2xTetO2 AmpR ZeoR) was
cut with BamHI and EcoRI so that each insert could be cloned
into the plasmid via NEBuilder HiFi DNA assembly reaction. The
primers AGO2350 and AGO2351 were used to amplify the fol-
lowing mNG-tagged ORFs for assembly into pAGB1139: WT
(creating pAGB1162), KH1 (creating pAGB1171), KH2 (creating
pAGB1172), KH1/2 (creating pAGB1173), ΔRGG (creating
pAGB1174), and ΔRGG KH1/2 (creating pAGB1175). Different re-
verse primers were used to amplify mNeonGreen-Fxr1isoE1-374
(AGO2374, creating pAGB1166) and mNeonGreen-Fxr1isoE1-490
(AGO2375, creating pAGB1167) for assembly into pAGB1139. To
create the mNG-tagged isoform A construct, isoform A was first
created in the pCMV isoform E background (creating pAGB936)
using primers AGO1863 and AGO1864 to remove aa 569–677 and
change aa 564–568 from DDSEK to GKRCD, and primers AGO1867
and AGO1868 to remove internal aa 308–408. To move this ORF
into the Tet-inducible system with an N-terminal mNG tag, mNG
was amplified from pAGB1103 with primers AGO2350 and
AGO2486, and Fxr1isoAwas amplified from pAGB936 with primers
AGO2487 and AGO2488. Both inserts were integrated into
pAGB1139 cut with BamHI and EcoRI via NEBuilder HiFi DNA
assembly reaction to create pAGB1189. All constructs and muta-
tions were verified by sequencing.
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Delivery of siRNAs into C2C12 cells
C2C12 cells were seeded into six-well plates (8 × 104 cells/well)
in DMEM supplemented with 10% FBS and 2 mM glutamine.
The next day, transfections were performed using Lipofect-
amine RNAiMax transfection reagent (Invitrogen) and Stealth
siRNAs (Invitrogen) following the manufacturer’s protocols.
The siRNA sequences were as follows: (1) si-luc (luciferase
reporter control, no. 12935146), 59-GCACUCUGAUUGACAAAU
ACGAUU-39 (sense) and 59-AAAUCGUAUUUGUCAAUCAGAG
UGC-39 (antisense); (2) si-Fxr1-#1 (MSS204455), 59-GCAAUCC
AUACAGCUUACUUGAUAA-39 (sense) and 59-UUAUCAAGUA
AGCUGUAUGGAUUGC-39 (antisense); and (3) si-Fxr1-#2 (MS
S204457), 59-GAAGUUGAUGCUUAUGUCCAGAAAU-39 (sense)
and 59-AUUUCUGGACAUAAGCAUCAACUUC-39 (antisense). The
next day, cells were washed with PBS and differentiation was
induced for 4–5 d.
Delivery of MOs into C2C12 cells
C2C12 myoblasts were seeded (8 × 104 cells/well) in DMEM
supplemented with 10% FBS and 2 mM glutamine into six-well
plates or six-well plates with 12-mm coverslips pretreated with
40 µg/ml PureCol (Advanced BioMatrix). The following day,
10–20 µMMOs (Gene Tools, LLC) were delivered using 6–10 µM
aqueous Endo-Porter (Gene Tools, LLC) following the suggested
protocol from the manufacturer. The MO oligo sequences were
as follows: (1) control, 59-CCTCTTACCTCAGTTACAATTTATA-
39; (2) Fxr1mo-1, 59-AACAGGCCCACTCAAGTTACCTGGC-39; and
(3) Fxr1 mo-2, 59-GCAACTGTGACTGTTAAAGATGAGA-39. The
day after delivery, cells were washed with PBS and differenti-
ated in DMEM supplemented with 2% horse serum and 2 mM
glutamine for 3–5 d.
Injection of MOs and sgRNAs in X. tropicalis and X. laevis
Xenopus were handled following the NIH Guidelines for Use and
Care of Laboratory Animals that were approved by the Institu-
tional Animal Care and Use Committee at the Marine Biological
Laboratory, Woods Hole, MA. In Fig. 1, C and D, Xtr.Tg(pax6:
GFP;cryga:RFP;act1:RFP)Papal (RRID:NXR_1021) embryos were
injected with 20 ng of mo-e15i15 or standard mo-control and
analyzed at stage 45. In Fig. 1, E and F, Xla.Tg(actc1:GFP)Mohun
(RRID:NXR_007) embryos were injected with 10 ng of standard
mo-control, 10 ng of mo-i14e15 (targeting both L and S genomes)
or coinjected with 1,500 pg of Cas9 protein plus 500 pg of each
sgRNA (T1, T3) and analyzed at stages 35–38. In Fig. 1 G, one cell
at the two-cell stage was injected with 250 pg of each sgRNA
(T7L, T7S, T8L, T8S) and 1,500 pg of Cas9 protein or with 10 ng
of mo-i14e15. Phenotypes were analyzed at stage 37-38. MO and
sgRNA sequence were as follows: (1) X. tropicalis mo-e15i15, 59-
GTAACTAAAGTGGGTGGAGCTATTG-39; (2) X. laevis mo-i14e15,
59-AAACTTTGCTGTTGCAGATGATAGT-39; (3) mo-control, 59-CC
TCTTACCTCAGTTACAATTTATA-39; (4) T1 sgRNA, 59-CCCCTGA
AGCGACGCCTGCGG-39; (5) T3 sgRNA, 59-GGCAGAAGATAGACA
GCCAGG-39; (6) T7L sgRNA, 59-ACTGCAGGTTGCAAACATATTG
G-39; (7) T7S sgRNA, 59-TACTATTGCTAGTCTTCAAGAGG-39; (8)
T8L sgRNA, 59-TCAGGACAATGGTTCTTAAATGG-39; and (9) T8S
sgRNA, 59-AAATGATAGAATGTCTAGTGTGG-39. All sgRNAs in-
clude a protospacer adjacent motif sequence.
RNA extraction
Frozen mouse tissues were homogenized using 1.4-mm ceramic
beads (Lysing Matrix D) and a Precellys-24 homogenizer (Bertin
Instruments) with the following setting: 6,500 rpm for 20-s
intervals until complete homogenization. RNA was then ex-
tracted using TRIzol (Invitrogen), following the manufacturer’s
protocol. For cell culture samples, TRIzol reagent was added to
the plates followed by RNA extraction per the manufacturer’s
suggested protocol. For Xenopus experiments, RNA was ex-
tracted from whole embryos (seven embryos per sample) using
TRIzol, following the manufacturer’s protocol. RNA concentra-
tion was measured with a NanoDrop Lite spectrophotometer
(ND-LITE; Thermo Fisher Scientific).
cDNA synthesis
Commercial human RNA samples or RNA extracted frommouse
tissues, Xenopus embryos, or cells was used to prepare cDNA
using the high-capacity cDNA reverse transcription kit (Applied
Biosystems) or the SuperScript IV kit (Invitrogen). The program
was as follows: (1) 25°C for 10 min, (2) 37°C for 120 min, (3) 85°C
for 5 min, and (4) 4°C pause.
Analysis of Fxr1 alternative splicing
The synthesized cDNA was used to perform PCR assays with the
mouse (0.5 µM), X. tropicalis (0.4 µM), or human primers (0.5
µM) targeting the constitutive exons flanking the alternative
regions. The sequences of the primers (Sigma or IDT) were as
follows: (a) mouse Fxr1-81-92-f (59-TGCTGTTCTGATGGATGG
AC-39) and mouse Fxr1-81-92-r (59-GAAGCGCTAGTTGGACCA
TT-39) to analyze the inclusion of exons 15 (81 nt) and 16 (92 nt;
expected bands 300, 219, 208, 127 bp); (b) mouse Fxr1-87-78-f
(59-AGAAAGCATTGGGAATGTGC-39) and mouse Fxr1-87-78-r
(59-TGTCTCGCTGATGTCGAGTC-39) to analyze the insert within
exon 12 (87 nt) and the alternative splice site in exon 13 (ex-
pected bands 377, 299, 290, 212 bp); (c) human FXR1-81-92-f
(59-TGCTGTTCTGATGGATGGAA-39) and human FXR1-81-92-r
(59-AGCACTAGTTGGGCCGTTTA-39) to analyze the inclusion of
exons 15 (81 nt) and 16 (92 nt) (expected bands 298, 217, 206, 125
bp); (d) X. tropicalis fxr1-F1 (59-TCTCACCACAACACAAACCG-39)
and X. tropicalis fxr1-R1 (59-GCGGAATCTACCTAAAGAACC-39) to
analyze the inclusion of exon 15 (81 nt; expected bands 266, 185
bp); and (e) X. tropicalis eef1a1-F (59-CCCCTCTTGGTCGTTTTG
CTGTCC-39; spans junction between exons 7 and 8) and X. tro-
picalis eef1a1-R (59-TTGCCTTTCTGTGCTTTCTGAGCAG-39; end
of coding sequence in exon 8) used as a loading control (expected
band 135 bp). PCRs for C2C12 cells, mouse tissues, and human
samples were performed using GoTaq green master mix
(Promega) and the following amplification conditions: (1) 95°C
for 1 min 15 s; (2) 28 cycles of 95°C for 45 s, 57°C for 45 s, 72°C
for 1 min; (3) 72°C for 10 min; and (4) 4°C pause. PCR products
were separated by 6% PAGE in TBE buffer (89 mM Tris, 89 mM
boric acid, and 2.5 mM EDTA, pH 8.3) for 3–4 h at 165 V. After
electrophoresis, the gels were stained with 0.4 µg/ml ethidium
bromide in water for 10 min and visualized using the ChemiDoc
XRS+ imaging system (Bio-Rad). Quantification of gels was
performed by densitometry using Image Lab 6.0.1 software
(Bio-Rad) for analysis. In X. tropicalis experiments, PCRs
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were performed using Taq Polymerase (NEB standard proto-
col) and the following amplification conditions: (1) 95°C for
1 min; (2) 27 cycles of 90°C for 30 s, 60°C for 30 s, 72°C for 16 s;
(3) 72°C for 5 min; and (4) 4°C pause. PCR products were sep-
arated by 2% agarose gel electrophoresis for 40 min at 135 V.
Real-time PCR (quantitative PCR [qPCR])
A 20-µl reaction with TaqMan Fast Advanced Master Mix (Ap-
plied Biosystems) was used to quantify 50–100 ng of cDNA with
TaqMan probes for Fxr1 (Mm00484523-m1, amplicon size 73 bp;
Applied Biosystems) and Hmbs (Mm01143545-m1, amplicon size
81 bp; Applied Biosystems) transcripts. An Applied Biosystems
StepOnePlus Real-Time PCR System was used and the thermal
cycling profile was as follows: (1) 50°C for 2 min; (2) 95°C for
20 s; and (3) 40 cycles of 95°C for 1 s, 60°C for 20 s. The cycle
threshold values of quantified transcripts were normalized to
that of a reference gene (Hmbs) from the same sample.
Protein extraction from mouse tissues
Frozen tissues were homogenized with 1.4-mm ceramic beads
(Lysing Matrix D’; MP Biomedicals) in a Hepes/sucrose buffer
(10 mM Hepes, 320 mM sucrose, and 1% SDS) supplemented
with protease and phosphatase inhibitors (Sigma). The Precellys-
24 homogenizer was used at 6,500 rpm for 20-s intervals until
complete tissue homogenization. Samples were then sonicated in
an ice water bath for 3 min (30-s bursts) at 75 V. Lysates were
collected after spinning at 14,000 rpm for 10 min at 4°C, and the
protein concentration was measured using the Pierce BCA pro-
tein assay kit (Thermo Fisher Scientific).
Protein extraction from cell culture
Cells were lysed in RIPA buffer (1% Triton X-100, 0.1% SDS, 0.5%
sodium deoxycholate, 150 mM NaCl, 50 mM Tris, and 5 mM
EDTA, pH 8.0) supplemented with protease and phosphatase
inhibitors (Roche). Cell lysates were sonicated for 3 min (30-s
bursts) at 75 V. After spinning at 14,000 rpm for 10 min at 4°C,
supernatants were collected and protein concentration was
measured using the Pierce BCA protein assay kit. To analyze
insoluble aggregates by Western blot, C2C12 or U2OS cells were
lysed in NETN lysis buffer (250 mM NaCl, 5 mM EDTA, pH 8.0,
50 mM Tris-HCl, pH 8.0, and 0.5% NP-40) supplemented with
protease inhibitors for 30 min on ice. Lysates were clarified by
centrifugation for 10 min at 13,000 rpm at 4°C. The soluble ly-
sate was separated from the pellet, and the pellet was re-
suspended in 50 µl of lysis buffer. Equivalent fractions were run
on an SDS-PAGE gel for analysis via Western blotting.
Western blot assays
Protein samples (25 µg; Figs. 3 C and 4 E; and Figs. S2 C and S3 A)
prepared in loading buffer (62.5 mM Tris-HCl, 10% glycerol, 2%
SDS, 0.02% bromophenol blue, 143 mM β-mercaptoethanol, and
5 mM DTT, pH 6.8) were boiled for 5 min and then loaded into
10%Mini-Protean Tris-Glycine eXtended Stain-Free precast gels
(Bio-Rad). Electrophoresis was performed in a buffer containing
25 mM Tris, 190 mM glycine, and 0.1% (wt/vol) SDS, pH 8.3, for
2 h at 120 V. After electrophoresis, the gels were exposed to UV
light for 2.5 min to activate Tris-Glycine eXtended within the gel
or counterstained with Ponceau stain solution for total protein
visualization. Proteins were transferred onto 0.45-µm poly-
vinylidene fluoride Immobilon-FL membranes (Millipore
Sigma) and visualized using the ChemiDoc XRS+ imaging sys-
tem. Membranes were blocked with 5% nonfat dried milk in
TBST buffer (19 mM Tris, 2.7 mM KCl, 137 mM NaCl, and 0.1%
Tween 20, pH 7.4) for 1 h, washed, and incubated overnight at
4°C with primary antibodies diluted in 5% BSA in TBST. Primary
antibodies were as follows: (1) rabbit monoclonal (EPR7932) anti-
FXR1 (ab129089; Abcam) diluted 1:1,000; (2) mouse monoclonal
anti-GAPDH (sc365062; Santa Cruz Biotechnology) diluted 1:500;
(3) mouse monoclonal anti–α tubulin (sc32293; Santa Cruz Bio-
technology) diluted 1:500; and (4) rabbit polyclonal anti–β tu-
bulin (ab6046; Abcam) diluted 1:1,000. The next day, the
membranes were washed three times (10 min each) with TBST
and then incubated for 1–1.5 h at RT in the darkness with a goat
polyclonal anti–rabbit IgG (H+L) DyLight 800 4X PEG (SA5-
35571; Invitrogen) diluted (1:10,000) in 5% BSA in TBST. Mem-
branes were washed three times (10 min each) with TBST, and
fluorescent signal was detected using the Odyssey CLx Blot Im-
ager (Li-Cor). Western blots (Figs. 4, 5, and 7) were performed as
described above, with the following differences. SDS-PAGE gels
were transferred to a nitrocellulose membrane and subsequently
blocked for 2 d in 5%milk in 50mMTris, 150mMNaCl, and 0.1%
Tween 20. Membranes were washed and incubated overnight
at 4°C with primary antibodies. Primary antibodies were as
follows: (1) rabbit monoclonal (EPR7932) anti-FXR1 (ab129089;
Abcam) diluted 1:1,000 and (2) rabbit anti-CDC2 (Santa Cruz
Biotechnology) diluted 1:1,000. The membranes were then
washed three times (10, 5, and 5 min) and incubated for 1 h at RT
with goat anti–rabbit IgG (H+L) (Bio-Rad). Membranes were
washed and signal was detected using the ChemiDoc XRS+
imaging system.
Immunofluorescence assays
Cells in plates or coverslips were washed three times with PBS
and fixed in 4% paraformaldehyde (Electron Microscopy Sci-
ences) in PBS for 20 min at RT. Cells were washed three times in
PBS, incubated in blocking solution (137 mM NaCl, 2.7 mM KCl,
9.6 mM Na2HPO4, 1.5 mM KH2PO4, 1% BSA, and 0.3% Triton X-
100, pH 7.4) for 1 h at RT, and then incubated with the primary
antibodies diluted in blocking solution overnight at 4°C. Primary
antibodies were as follows: (1) rabbit monoclonal (EPR7932)
anti-FXR1 (ab129089; Abcam) diluted 1:250 and (2) mouse
monoclonal (B-5) anti–myosin heavy chain (MYH; sc-376157;
Santa Cruz Biotechnology) diluted 1:50. The next day, cells
were washed three times (10 min each) with PBS and then in-
cubated with the appropriate secondary antibody diluted in
blocking solution for 1 h at RT in the darkness. Secondary an-
tibodies were as follows: (1) rabbit polyclonal anti–mouse IgG
(H+L) Alexa Fluor 488 (A21204; Invitrogen) diluted 1:500 and (2)
goat polyclonal anti–rabbit IgG (H+L) Alexa Fluor 488 (A11008;
Invitrogen) diluted 1:250. Cells were washed three times (10 min
each) with PBS and then stained with 2 µM DAPI in PBS for
5 min at RT in the darkness. Cells were washed three times
(5 min each) in PBS and imaged by confocal microscopy in PBS.
When cells were stained with phalloidin, incubation with Alexa
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Fluor 647 Phalloidin (A22287, dilution 1:40; Invitrogen) was
performed concurrently with the secondary antibody.
Confocal microscopy for cells
For imaging in Fig. S3, confocal microscopy was performed in
the Hooker Imaging Core (University of North Carolina Chapel
Hill, Chapel Hill, NC) using an LSM 880 confocal microscope
(Zeiss) with a 10× Plan Apochromat objective (0.45 working
distance) and Zen Black (Zeiss) software for image acquisition.
Excitation parameters were as follows: argon multiline laser at
488 nm (Alexa Fluor 488; 2% power), a 405-nm diode at 30 mW
(DAPI; 2% power), or a helium-neon laser at 633 nm (2% power).
Emission filters were set up as follows: 490–615 nm (Alexa Fluor
488), 410–514 nm (DAPI), and 638–747 nm (Alexa Fluor 647).
Cells were imaged at RT. For imaging in Fig. 4 C, live cells were
imaged at RT on a Quorum WaveFX spinning disk confocal
system equipped with a Plan Apochromat 60× 1.4 numerical
aperture objective. Images were acquired on an electron
multiplying-charged coupled device camera (C9100-13; Hama-
matsu) driven by MetaMorph software version 7.8.12.0 (Mo-
lecular Devices). A 488-nm laser was used for GFP excitation
using 20% laser power, 500-ms exposure, and 200 gain. Cells
were imaged every 15 s through the complete depth of the cell
with 0.5-µm inter-plane spacing. For Fig. 4, B and G; and Figs. 5
and 7, fixed or live cells were imaged on Yokogawa CSU-W1
spinning disk confocal system equipped with a VC Plan Apo 60×
1.49 numerical aperture oil immersion objective at RT. Fixed
cells were imaged in 1× PBS, while live cells were imaged in
FluoroBrite DMEM (Gibco). Images were acquired using an
sCMOS 85% QE camera (Photometrics) driven by Nikon Ele-
ments Software. For Fig. 4, B and G the following parameters
were used: 488-nm laser (Alexa Fluor 488) at 25% power and
200-ms exposure, 405 nm laser (Hoechst) at 15% power and 100-
ms exposure, and 640-nm laser (Alexa Fluor 647 Phalloidin) at
50% power and 100-ms exposure. For Figs. 5 and 7, the following
parameters were used: 488-nm laser (mNG) at 25% power and
100-ms exposure and 405-nm laser (Hoechst) at 15% power and
100-ms exposure. For Fig. 4, there is no correlation between the
CV and mean fluorescence intensity of the cell. Droplets were
scored as spherical or irregular based on their aspect ratio. Small
clusters were composed of fewer than four droplets.
Microscopy in Xenopus experiments
Images of Xenopus tadpoles in Fig. 1 were acquired at RT in
imaging media (0.1× Marc’s Modified Ringer’s Solution) on a
Zeiss SteREO Discovery.V12 microscope with an Achromat S
1.25× objective and a mounted Zeiss AxioCam MRc camera
controlled with the ZEN 2 lite (blue edition) software version
2.0.0.0. The filter blocks 45 Texas Red/FRFP and 57 GFP LP (long
pass) were used to acquire red or green fluorescent images,
respectively. Prior to imaging, the tadpoles were anesthetized
until complete loss of mobility using 0.1% Tricaine-S (Western
Chemical, Inc.) buffered to pH 7.4 with NaHCO3.
Protein purification
FXR1 isoforms A and E were cloned into the His-GB1 vector and
Sanger sequenced to confirm insert. Plasmids were transformed
into BL21 bacteria. 2xYT media containing kanamycin was in-
oculated with a colony of freshly transformed BL21 (DE3). Cul-
tures were grown at 37°C overnight with shaking. The next
morning, the starter culture was diluted 1:60 and was incubated
at 37°C for 2 h and then at 30°C until culture reached an OD of
0.6–0.7. The culture was induced with 1 mM IPTG and then
incubated at 30°C for 6 h. Cells were pelleted at 10,000 rpm for
5 min, and pellets were resuspended in 1.5 M KCl, 50mMHepes,
pH 7.4, 20 mM imidazole, 5 mM β-mercaptoethanol, 1.5 ml of
10 mg/ml lysozyme, and protease inhibitor for 30 min at 4°C.
Samples were then sonicated (10 s on, 2 min off, 10 s on) until
homogenous. Samples were centrifuged at 20,000 rpm for
30 min, and the supernatant was passed through a 0.44-µm
filter using a 60-ml syringe. FXR1 was purified from the su-
pernatant using a Ni- or Co-nitrilotriacetic acid column follow-
ing standard protocols for Whi3 purification (Langdon et al.,
2018). Purified proteins were analyzed by SDS-PAGE and
Coomassie staining.
CK2 in vitro phosphorylation assay
In vitro phosphorylation reactions were performed according to
the manufacturer’s instructions (P6010S; NEB) using 0.9 nmol
of protein with control phosphorylation performed in the ab-
sence of ATPwith all other reaction components. Reactions were
incubated for 50 min at 30°C. In the last 10 min of incubation,
60 µM Atto 488 dye (41051-1MG-F; Sigma) was added to the
reaction. Following incubation and labeling (1 h total), samples
were buffer exchanged using CENTRI SPIN-20 columns (CS-201;
Princeton Separations) according to the manufacturer’s in-
structions to remove the buffer, excess dye, and ATP. Protein
concentration was requantified using a nanodrop. Phospho-
rylation was confirmed by gel electrophoresis followed by
Coomassie staining.
In vitro transcription
Cy5-labeled luciferase RNA was produced according to the
manufacturer’s instructions (E2040S; NEB) labeled with 6%
Cy5-UTP (PA53026; Millipore Sigma). Reaction was incubated at
37°C overnight and precipitated using 2.5 M LiCl. Pellets were
washed three times with 70% ethanol in diethylpyrocarbonate-
treated water. RNA samples were eluted in diethylpyrocarbonate-
treatedwater and quantified using a nanodrop. In vitro–transcribed
RNA (∼5 µg) was analyzed by agarose gel electrophoresis to con-
firm the presence of a single band with the appropriate size.
In vitro assays
Luciferase RNA (10 nM) and 2 or 4 µM FXR1 isoforms A and E
(Atto 488 labeled) were mixed in droplet buffer (150 mM KCl,
20 mM Hepes, and 1 mM β-mercaptoethanol, pH 7.4) and added
to 30 mg/ml fatty acid–free BSA (A8806; Sigma) in droplet
buffer–blocked chamber slides (2024-03; Grace Bio-Labs) and
incubated at RT for 3 h before imaging.
Image processing and quantitative analysis
Processing of microscopy images and quantitative analysis were
performed using Fiji software (Schindelin et al., 2012; Schneider
et al., 2012) or ImageJ software (National Institutes of Health).
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Images were identically contrasted with respect to black-and-
white values within each figure. The fusion index was estimated
as the ratio between the number of nuclei within MYH-positive
cells with more than two nuclei and the total number of nuclei.
To quantify the CV in Fig. 4, a region of interest was first drawn
around the most focused z-stack for each cell with more than
two nuclei excluding the nuclei. The mean gray value was ac-
quired in the FXR1 channel by calculating the sum of the gray
values of all the pixels in the region of interest divided by the
number of pixels. This value was then background subtracted.
The SD of the gray values for each cell was then quantified. The
CV was then calculated by dividing the SD of a cell by its
background-subtracted mean gray value. For droplet formation
analysis, cells were visually scored for either having droplets or
not. For morphology quantification, cells were visually scored
for the three morphology categories observed. For in vitro as-
says, images were quantified using Fiji software as follows:
Protein signal (488) was used to threshold to white level of 137
(a.u.), and the Analyze Particle plugin was used to define the
area of the particles in the image. These regions of interest were
then used to extract the RNA and protein fluorescent signal.
Three images from three replicates were used for quantification.
Software
Protein disorder was predicted using the IUPRED algorithm
(Dosztányi et al., 2005a, 2005b). The aa composition of the
C-terminal IDD of FXR1 was determined using IDD Navigator
with IUPRED disordered domain prediction (Patil et al., 2012)
along with the ProtParam tool (https://web.expasy.org/protparam/);
Wilkins et al., 1999). For phosphorylation prediction, the se-
quences of the His-GB1-FXR1 A/E, or FMR1 (uniprot) were ana-
lyzed using the NETphos 3.1 predictor (serine phosphorylation)
and IUPRED (disorder).
Statistics
All data are presented as the mean ± SEM. The P values were
estimated by a Student’s t test (two tailed) or one-way ANOVA
with Bonferroni’s test for multiple comparisons. P ≤ 0.05 was
considered statistically significant.
Online supplemental material
Fig. S1 shows the sequences of fxr1 exon 15 from sgRNA-treated
embryos. Fig. S1 is linked to Fig. 1, E and F. Fig. S2 shows the
splicing events in exons 12 and 13 of Fxr1 pre-mRNA and ex-
pression of FXR1 protein isoforms during tissue development.
Fig. S2 is linked to Fig. 2. Fig. S3 shows that FXR1 is required for
myogenesis. Fig. S3 is linked to Figs. 3 and 4. Fig. S4 shows that
RNA addition and protein phosphorylation influence FXR1 ag-
gregation in vitro. Fig. S4 is linked to Fig. 6. Table S1 details the
primers used for cloning.
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Dosztányi, Z., V. Csizmók, P. Tompa, and I. Simon. 2005b. The pairwise
energy content estimated from amino acid composition discriminates
between folded and intrinsically unstructured proteins. J. Mol. Biol. 347:
827–839. https://doi.org/10.1016/j.jmb.2005.01.071
Elbaum-Garfinkle, S., Y. Kim, K. Szczepaniak, C.C.-H. Chen, C.R. Eckmann, S.
Myong, and C.P. Brangwynne. 2015. The disordered P granule protein
LAF-1 drives phase separation into droplets with tunable viscosity and
dynamics. Proc. Natl. Acad. Sci. USA. 112:7189–7194. https://doi.org/10
.1073/pnas.1504822112
Estañ, M.C., E. Fernández-Núñez, M.S. Zaki, M.I. Esteban, S. Donkervoort, C.
Hawkins, J.A. Caparros-Martin, D. Saade, Y. Hu, V. Bolduc, et al. 2019.
Recessive mutations in muscle-specific isoforms of FXR1 cause con-
genital multi-minicore myopathy.Nat. Commun. 10:797. https://doi.org/
10.1038/s41467-019-08548-9
Fay, M.M., P.J. Anderson, and P. Ivanov. 2017. ALS/FTD-associated C9ORF72
repeat RNA promotes phase transitions in vitro and in cells. Cell Rep. 21:
3573–3584. https://doi.org/10.1016/j.celrep.2017.11.093
Gessert, S., V. Bugner, A. Tecza, M. Pinker, and M. Kühl. 2010. FMR1/FXR1
and the miRNA pathway are required for eye and neural crest devel-
opment. Dev. Biol. 341:222–235. https://doi.org/10.1016/j.ydbio.2010.02
.031
Giudice, J., Z. Xia, E.T. Wang, M.A. Scavuzzo, A.J. Ward, A. Kalsotra, W.
Wang, X.H.T. Wehrens, C.B. Burge, W. Li, and T.A. Cooper. 2014. Al-
ternative splicing regulates vesicular trafficking genes in cardiomyocytes
during postnatal heart development. Nat. Commun. 5:3603. https://doi.org/
10.1038/ncomms4603
Greenblatt, E.J., and A.C. Spradling. 2018. Fragile X mental retardation 1 gene
enhances the translation of large autism-related proteins. Science. 361:
709–712. https://doi.org/10.1126/science.aas9963
Hartley, K.O., Z. Hardcastle, R.V. Friday, E. Amaya, and N. Papalopulu. 2001.
Transgenic Xenopus embryos reveal that anterior neural development
requires continued suppression of BMP signaling after gastrulation.
Dev. Biol. 238:168–184. https://doi.org/10.1006/dbio.2001.0398
Haynes, C., and L.M. Iakoucheva. 2006. Serine/arginine-rich splicing factors
belong to a class of intrinsically disordered proteins. Nucleic Acids Res.
34:305–312. https://doi.org/10.1093/nar/gkj424
Hofweber, M., and D. Dormann. 2019. Friend or foe-Post-translational
modifications as regulators of phase separation and RNP granule
dynamics. J. Biol. Chem. 294:7137–7150. https://doi.org/10.1074/jbc
.TM118.001189
Hollingworth, D., A.M. Candel, G. Nicastro, S.R. Martin, P. Briata, R. Gherzi,
and A. Ramos. 2012. KH domains with impaired nucleic acid binding as
a tool for functional analysis. Nucleic Acids Res. 40(14):6873–6886. .
https://doi.org/10.1093/nar/gks368
Huot,M.-E., N. Bisson, L. Davidovic, R.Mazroui, Y. Labelle, T. Moss, and E.W.
Khandjian. 2005. The RNA-binding protein fragile X-related 1 regulates
somite formation in Xenopus laevis.Mol. Biol. Cell. 16:4350–4361. https://
doi.org/10.1091/mbc.e05-04-0304
Khandjian, E.W., B. Bardoni, F. Corbin, A. Sittler, S. Giroux, D. Heitz, S.
Tremblay, C. Pinset, D. Montarras, F. Rousseau, and J. Mandel. 1998.
Novel isoforms of the fragile X related protein FXR1P are expressed
during myogenesis. Hum. Mol. Genet. 7:2121–2128. https://doi.org/10
.1093/hmg/7.13.2121
Kiebler, M.A., and G.J. Bassell. 2006. Neuronal RNA granules: movers and
makers. Neuron. 51:685–690. https://doi.org/10.1016/j.neuron.2006.08
.021
Kim, T.H., B. Tsang, R.M. Vernon, N. Sonenberg, L.E. Kay, and J.D. Forman-
Kay. 2019. Phospho-dependent phase separation of FMRP and CAPRIN1
recapitulates regulation of translation and deadenylation. Science. 365:
825–829. https://doi.org/10.1126/science.aax4240
Kirkpatrick, L.L., K.A. McIlwain, and D.L. Nelson. 1999. Alternative splicing
in the murine and human FXR1 genes. Genomics. 59:193–202. https://doi
.org/10.1006/geno.1999.5868
Langdon, E.M., Y. Qiu, A. Ghanbari Niaki, G.A. McLaughlin, C.A. Weidmann,
T.M. Gerbich, J.A. Smith, J.M. Crutchley, C.M. Termini, K.M. Weeks,
et al. 2018. mRNA structure determines specificity of a polyQ-driven
phase separation. Science. 360:922–927. https://doi.org/10.1126/science
.aar7432
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Supplemental material
Figure S1. Sequences of fxr1 exon 15 from sgRNA-treated embryos. Sequences of fxr1.S and fxr1.L from five randomly selected X. laevis embryos injected
with the sgRNA T1 (green) and T3 (underlined). sgRNA-injected embryos had deletions (dashed), uncallable nucleotides (N), and mismatches (red) compared
with reference sequences. Deletions roughly correspond to 3–4 nt upstream of the protospacer adjacent motif (PAM) sequences (magenta). Fig. S1 is linked to
Fig. 1, E and F.
Smith et al. Journal of Cell Biology S1
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Figure S2. Alternative splicing events in exons 12 and 13 of Fxr1 pre-mRNA and expression of FXR1 protein isoforms during tissue development.
(A) Scheme of part of Fxr1 gene showing the alternative splicing events in exons 12 (insert of 87 nt) and exon 13 (alternative splice site leading to the inclusion
or skipping of a 78-nt region). To evaluate the splicing patterns by RT-PCR, the primers designed to target the constitutive flanking exons were Fxr1-87-78-f
(forward) and Fxr1-87-78-r (reverse). (B) Different tissues were collected from neonatal (P4.5) and adult (4-mo-old) mice. Alternative splicing was evaluated by
RT-PCR and quantified by densitometry. n = 3–4 (P4.5 tissues) samples from two to nine pooled neonates each depending on tissue type, n = 4 (adult tissues)
animals. (C) Adult mouse tissues were evaluated by Western blots using a monoclonal antibody against the N terminus of FXR1 protein that thus recognizes all
of the splice variants. n = 2 animals. Data are means ± SEM, *P ≤ 0.05 (one-way ANOVA test with Bonferroni correction for multiple comparisons). sk muscle,
skeletal muscle. Fig. S2 is linked to Fig. 2.
Smith et al. Journal of Cell Biology S2
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Figure S3. FXR1 is required for myogenesis. (A–E) C2C12 myoblasts were transfected with two different siRNAs targeting Fxr1 (#1, #2) or a control siRNA
(si-luc), and the next day differentiation was induced. Protein and RNA were collected at differentiation day 4, and FXR1 depletion was confirmed by Western
blot and qPCR assays (A). Cells were evaluated by immunofluorescence to confirm knockdown. Scale bars, 100 µm (B). MYH expression was evaluated by
immunofluorescence (C), and the fusion index was estimated (D). The number of nuclei per field of view was estimated from the microscopy images (E). Data
are means ± SEM, *P ≤ 0.05 versus mock and si-luc (Student’s t test, two sided), n = 4–8 independent experiments. Scale bars, 200 µm. (F–I) MOs were
delivered in undifferentiated myoblasts, and the next day cells were differentiated for 4 d. Scheme of the MOs used to target exons 15 (mo-1) and 16 (mo-2)
where control denotes cells treated with a MO control (F). Efficiency of MO action was evaluated by RT-PCR (G) and quantified (H). Total Fxr1 mRNA levels
were evaluated by qPCR (I). mo-1& 2 indicates that cells were treated with both mo-1 and mo-2 at the same time. Data are means ± SEM, *P ≤ 0.05 versus
mock and control (Student’s t test, two sided), n = 3–8 independent experiments. Fig. S3 is linked to Figs. 3 and 4.
Smith et al. Journal of Cell Biology S3
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Figure S4. RNA addition and protein phosphorylation influence FXR1 aggregation in vitro. (A) Luciferase RNA accelerates isoform E aggregation.
Representative images for either 4 or 2 µM isoform E with or without luciferase RNA after 3, 4, 5, 6, and 24 h. Scale bars, 10 µm. (B) FMR1 Predicted disorder
(IUPRED) and unspecified kinase score for serine are marked for each aa. Predicted phosphorylated serines are uniformly distributed across the protein.
(C) Coomassie staining of the in vitro–purified FXR1 isoforms A and E. Phosphorylation (Phos) results in a band shift with respect to the control (Ctrl) or mock-
treated samples. (D) Representative images of 2 µM FXR1 isoform E (shown in white) with or without RNA and with or without phosphorylation (Phos) at 3, 4,
5, 6, and 24 h. Scale bars, 10 µm. Fig. S4 is linked to Fig. 6.
Smith et al. Journal of Cell Biology S4
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Provided online is one table. Table S1 shows the sequence of the primers (IDT) used for plasmid generation.
Smith et al. Journal of Cell Biology S5
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